lentiviral vector

Oxford BioMedica perfects lentiviral vectors for gene therapy

Tuesday 22 March 2011

Interviewee/Contributer: Stuart Naylor

Organisation: Oxford Biomedica Plc

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content